600422 昆药集团
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)7.1548.6517.84710.99610.567
总资产报酬率 ROA (%)3.9564.6814.1825.9675.873
投入资产回报率 ROIC (%)5.7336.6655.8638.5908.737

边际利润分析
销售毛利率 (%)40.91244.82041.51641.30143.156
营业利润率 (%)8.9217.3806.0037.6827.008
息税前利润/营业总收入 (%)9.4247.4506.2258.1307.472
净利润/营业总收入 (%)7.1565.8964.6546.2185.989

收益指标分析
经营活动净收益/利润总额(%)91.56997.60493.56067.23580.709
价值变动净收益/利润总额(%)2.4263.2543.49023.7122.659
营业外收支净额/利润总额(%)2.142-0.865-4.161-0.437-0.064

偿债能力分析
流动比率 (X)1.9121.9291.7401.7731.779
速动比率 (X)1.5131.4661.3081.2331.230
资产负债率 (%)43.00142.74645.47844.44743.332
带息债务/全部投入资本 (%)15.15815.14120.59219.10312.999
股东权益/带息债务 (%)530.859526.927360.966393.235627.971
股东权益/负债合计 (%)128.382129.559116.170121.017126.459
利息保障倍数 (X)30.59155.88513.45916.90515.963

营运能力分析
应收账款周转天数 (天)139.534116.55293.51171.02564.979
存货周转天数 (天)136.694142.666132.455133.796129.208